Latest & Greatest

Latest & Greatest

Recent developments in the field of hematology/oncology, including drug approvals, policy updates, and clinical trial results

FDA Approves NGS-Based Test for Patients With ALL or MM

The FDA authorized the next-generation sequencing (NGS)–based ClonoSEQ assay for the measurement of minimal residual disease (MRD) in patients with acute lymphocytic leukemia (ALL)...

NCI Releases 2020 Annual Plan and Budget Proposal

The National Cancer Institute (NCI) and its director Norman Sharpless, MD, recently released their annual plan and budget proposal for fiscal year 2020, in...

New Guidelines Call for “Seismic Shift” in Palliative-Care Delivery

In new guidelines published by the National Coalition for Hospice and Palliative Care, the National Consensus Project for Quality Palliative Care urges all health-care...

FDA Approves New Treatment for Hemophilia

The U.S. Food and Drug Administration (FDA) approved BAY94-9027, or antihemophilic factor (recombinant), PEGylated-aucl, for the prophylactic treatment of adults and adolescents (≥12 years)...

FDA Approves Ibrutinib Combo for Waldenström Macroglobulinemia

The U.S. Food and Drug Administration (FDA) approved ibrutinib, in combination with rituximab, for the treatment of adult patients with Waldenström macroglobulinemia (WM). In...

Elephants’ “Zombie Gene” May Prevent Cancer

Researchers have identified a gene that appears to solve the mystery of why elephants – who should be at a greater risk of developing...

Oncology Community Reacts to Medicare Advantage’s “Step Therapy” Decision

In early August 2018, the Centers for Medicare and Medicaid Services (CMS) announced it will allow Medicare Advantage plans to implement “step therapy” for...

Theranos Shutting Down Amid Fraud Allegations

In a letter to investors, the CEO of Theranos announced that the bloodtesting company is preparing to shut down. Theranos has faced a U.S....

FDA Warns Against Using Azithromycin After Stem Cell Transplant

The U.S. Food and Drug Administration (FDA) issued a statement advising clinicians to avoid using the antibiotic azithromycin in patients with certain cancers who...

FDA Approves Mogamulizumab-kpkc for Two Types of Non-Hodgkin Lymphoma

The U.S. Food and Drug Administration (FDA) approved mogamulizumab-kpkc for intravenous use in patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome...
Advertisement

Current Issue

January 2019 Annual Meeting Edition

This issue features highlights from the 2018 ASH Annual Meeting, including big data initiatives to improve prognosis in myelodysplastic syndromes, and more.